ArchPoint Investors’s Allergan plc AGN Stock Holding History

ArchPoint Investors’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-9,000	Closed	-$2.07M	–	96
2016 Q3	$2.07M	Hold	9,000	–	–	1.18%	22
2016 Q2	$2.08M	Buy	9,000 +7,940	+749%	+$1.83M	1.19%	20
2016 Q1	$284K	Hold	1,060	–	–	0.16%	71
2015 Q4	$331K	Sell	1,060 -500	-32%	-$149K	0.23%	67
2015 Q3	$424K	Buy	+1,560	New	+$479K	0.29%	53

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

ArchPoint Investors's AGN Position: Q4 2016 in Review

ArchPoint Investors sold out of Allergan plc (AGN) in Q4 2016, closing a stake of 9,000 shares — an estimated $2.07M sold.

ArchPoint Investors first reported a position in AGN in Q3 2015 and held it in 5 quarters. The position peaked at $2.08M in Q2 2016. 1,091 funds tracked by Wall St. Rank hold AGN as of Q4 2016.

ArchPoint Investors reported no remaining Allergan plc position as of Q4 2016 after selling out during the quarter.
ArchPoint Investors sold 9,000 Allergan plc shares in Q4 2016, an estimated $2.07M.
ArchPoint Investors first reported a position in Allergan plc in Q3 2015 and held it in 5 quarters.
ArchPoint Investors's Allergan plc position peaked at $2.08M in Q2 2016.
1,091 funds tracked by Wall St. Rank held Allergan plc as of Q4 2016.

Based on ArchPoint Investors's 13F filing for Q4 2016, filed 14 Feb 2017.